Leo Cancer Care Company Research Report

Company Overview

• Name: Leo Cancer Care

• Mission: Leo Cancer Care is committed to challenging the conventions of radiotherapy by reintroducing the practice of treating patients in an upright position, aiming to improve patient experience and develop products designed for the future of healthcare.

• Founded: No information is available

• Founders: No information is available

• Key People:

• Stephen Towe, Chief Executive Officer

• Rock Mackie, Co-Founder

• Jennifer Xistris, Chief Human Resources Officer

• Mike Bauer, Chief Commercial Officer

• Andy Harley, Chief Financial Officer

• Tom Casselden, Chief Operations Officer

• Niek Schreuder, Chief Scientific Officer

• Headquarters:

• UK Office: Unit 2, Arrow Point, Manor Royal, Crawley, West Sussex, RH10 9BT, United Kingdom

• USA Office: 7921 UW Health Court, Middleton, WI 53562, USA

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Leo Cancer Care is known for its upright radiation therapy solutions designed to offer improved patient experiences and enhanced efficiency in treatment delivery.

Products

Photon Therapy

• Product: Ruby™

• Description: Ruby is a complete upright image-guided photon radiotherapy treatment system. It eliminates the need for a rotating gantry and utilizes a fixed radiation beam with patient rotation.

• Key Features:

• Image-guided treatment with a fixed beam.

• Simplifies bunker construction due to reduced need for extensive shielding.

• Enhances patient interaction with direct eye contact with clinicians.

Particle Therapy

• Product: Marie®

• Description: Marie is a comprehensive upright particle therapy solution that combines patient positioning with a CT scanner, enabling simulation and treatment from a fixed particle beam.

• Key Features:

• Gantry-less design allowing for reduced facility size and cost.

• Adaptable to various particle beam therapies such as proton, carbon ion, neutron, and FLASH therapy.

• Enhanced patient comfort and reduced organ motion due to the upright positioning.

Recent Developments

• New Products:

• The introduction of the MEVION S250-FIT Proton Therapy System at Stanford Health Care, integrating Leo Cancer Care's Marie upright patient positioning system.

• New Partnerships:

• Partnership with Anzai Medical Co., Ltd. to distribute Leo Cancer Care’s systems in Japan, marking expansion into Asian markets.

• Collaborations with Aviko Radiopharmaceuticals and Neutron Therapeutics for developing Boron Neutron Capture Therapy (BNCT).

• Partnership with TheryQ focusing on developing FLASHDEEP, a high-dose rapid radiation treatment option.

• Strategic Initiatives:

• Leo Cancer Care has formed strategic partnerships with beam providers such as Mevion Medical Systems, Hitachi, LinearBeam, ProNova Solutions, and ProTom International to enhance accessibility to cancer care worldwide through their Marie solution.

• Regulatory Milestones:

• Leo Cancer Care's upright patient positioning system has received 510(k) regulatory clearance in the USA for clinical use, with similar processes underway in Europe and Asia.

This report synthesizes available information about Leo Cancer Care, highlighting their innovations in the field of radiation therapy through an upright patient-oriented approach.